KIR2DL4/HLA‐G polymorphisms were associated with HCV infection susceptibility among Chinese high‐risk population

Author:

Feng Zepei12,Huang Peng1ORCID,Zhang Jinwei3,Xia Xueshan45ORCID,Zhang A‐mei4,Zeng Tian6,Chen Qiong7,Zhu Chuanlong68,Tan Weilong9ORCID,Zhang Yun27,Yue Ming6ORCID

Affiliation:

1. Department of Epidemiology and Biostatistics, Key Laboratory of Infectious Diseases, School of Public Health Nanjing Medical University Nanjing China

2. Department of Epidemiology, Center for Global Health, School of Public Health Nanjing Medical University Nanjing China

3. Department of Anesthesiology Affiliated Drum Tower Hospital of Medical College of Nanjing University Nanjing China

4. Faculty of Life Science and Technology Kunming University of Science and Technology Kunming China

5. School of Basic Medicine Kunming Medical University Kunming China

6. Department of Infectious Diseases The First Affiliated Hospital of Nanjing Medical University Nanjing China

7. Institute of Epidemiology and Microbiology Eastern Theater Command Centers for Disease Prevention and Control Nanjing China

8. Department of Tropical Diseases The Second Affiliated Hospital of Hainan Medical University Hainan China

9. Nanjing Bioengineering (Gene) Technology Center for Medicines Nanjing China

Abstract

AbstractKiller‐cell immunoglobulin‐like receptors 2DL4 (KIR2DL4) and the human leukocyte antigen class I‐G (HLA‐G) display vital parts in immune responses against hepatitis C virus (HCV) infection. We select four potentially functional single nucleotide polymorphisms (SNPs) of KIR/HLA to explore the associations between KIR2DL4/HLA‐G genetic variants and HCV infection results. In the present case‐control study, a total of 2225 HCV‐infected high‐risk subjects, including 1778 paid blood donors (PBD) and 447 drug users were consecutively recruited before treatment from 2011 to 2018. KIR2DL4‐rs660773, KIR2DL4‐rs660437, HLA‐G‐rs9380142, and HLA‐G‐rs1707 SNPs were sorted as genotypes in the subdivided groups, involving 1095 uninfected controls subjects, 432 spontaneous HCV clearance subjects and 698 HCV persistent infection subjects. After genotyping experiments using the TaqMan‐MGB assay, modified logistic regression was used to calculate the correlation among the SNPs and HCV infection. The SNPs were functionally annotated using bioinformatics analysis. Following adjusting by age, sex, alanine aminotransferase, aspartate aminotransferase, IFNL3‐rs12979860, IFNL3‐rs8099917, and the infection route, the logistic regression analysis discovered that KIR2DL4‐rs660773 and HLA‐G‐rs9380142 were correlated with vulnerability to HCV infection (all p < 0.05). In a locus‐dosage way, compared with subjects carrying the rs9380142‐AA or rs660773‐AA genotypes, subjects with rs9380142‐AG or rs660773‐AG/GG (all p < 0.05) were more vulnerable to HCV infection; the overall impact of their risk genotypes (rs9380142‐AGrs660773‐AG/GG) was correlated with an elevated incidence of HCV infection (ptrend < 0.001). In the Haplotype analysis, patients with haplotype AG were more likely to contract HCV compared to those with the highest common AA haplotype (p = 0.002) were higher in susceptibility to infect HCV. The SNPinfo web server estimated that rs660773 is a transcription factor binding site, whereas rs9380142 is a potential microRNA‐binding site. In two Chinese high‐risk population (PBD and drug uesrs), KIR2DL4 rs660773‐G and HLA‐G rs9380142‐G alleles polymorphisms are related to HCV susceptibility. KIR2DL4/HLA‐G pathway genes might affect the innate immune responses by regulating KIR2DL4/HLA‐G transcription and translation play a potential role in HCV infection.

Publisher

Wiley

Subject

Infectious Diseases,Virology

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3